Design of drugs involving receptor-ligand-DNA interactions

Details Design of drugs involving receptor-ligand-DNA interactions Design of drugs involving receptor-ligand-DNA interactions

1997-05-28

1999-03-30

Degen, Nancy

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

36446804, C12Q 168, G06F 1900

Patent

active

058887385

ABSTRACT:
It has been discovered that the degree of hormonal activity of candidate ligands correlates better with degree of fit into DNA than with the strength of receptor binding, and that the receptors in the steroid/thyroid hormone/vitamin A and D family alter the physiochemical properties of DNA and in concert with other transcription factors facilitate insertion of the ligand into DNA. As a result, the magnitude of the response is a function of the structure of the ligand as it related to insertion and fit into the DNA and the specificity of the response is a function of the stereochemistry of the receptor through binding to both the ligand and to the DNA. Based on these discoveries, a method is described herein for identifying drugs having increased activity as compared with the natural ligand for receptors such as the estrogenic receptors.

REFERENCES:
patent: 4461619 (1984-07-01), Hendry et al.
patent: 4705796 (1987-11-01), Hendry et al.
patent: 5238947 (1993-08-01), Hendry et al.
Lehninger, Biochemistry, Second Edition, Worth Publishers, Inc. pp. 822-824, 1975.
Hendry et al., J. Steroid Biochem. Molec. Biol., vol. 42, pp. 659-670 (1992).
Hendry et al., J. Steroid Biochem. Molec. Biol., vol. 41, pp. 647-651 (1992).
Witham and Hendry, J. Theor. Biol., vol. 155, 42, pp. 55-67 (1992).
Hendry et al., J. Steroid Biochem. Molec. Biol., vol. 39, pp. 133-146 (1991).
Borman, Chem. Eng. News, vol. 70, pp. 18-26 (1992).
Brann et al., J. Steroid Biochem. Molec. Biol., vol. 52, pp. 113-133 (1995).
Bransome, J.Clin. Pharmacol., vol. 33, pp. 1147-1148 (1993).
Bransome et al., J. Theor. Biol., vol. 112, pp. 97-108 (1985).
Brooks et al., "Recent Advances in Steroid Hormone Action", Moudgil, V.K., (ed) pp. 443-466, Walther de Gruter, NY (1987).
Burzynski et al., Drugs of the Future, vol. 10, p. 103 (1985).
Copland et al., J. Steroid Biochem. Molec. Biol., vol. 46, pp. 451-562 (1993).
Denton et al., J. Biol. Chem., vol. 267, pp. 7263-7268 (1992).
Hendry et al., J. Steroid Biochem. Molec. Biol., vol. 48, pp. 495-505 (1994).
Hendry, J. Clin. Pharmacol., vol. 33, pp. 1173-1187 (1993).
Hendry, J. Steroid Biochem., vol. 31, pp. 493-523 (1988).
Hendry et al., J. Steroid Biochem., vol. 24, pp. 843-852 (1986).
Hendry et al., Proc. Natl. Acad. Sci. USA., vol. 78, pp. 7440-7444 (1981).
Hendry et al., Perspect. Biol. Med., vol. 27, pp. 623-651 (1984).
Hendry et al., "Recent Advances In Chemotherapy", Buchner and Rubinstein (eds), pp. 2498-2499 (1991).
Hendry et al., J. Steroid Biochem. Molec. Biol., vol. 49, No. 4-6, pp. 269-280 (1994).
Hilgard, A.G. and Hummel, D.J. (eds), "Endocrine Bioassay Data", Part III, U.S. Dept. HEW NIH (1964).
Lee et al., J. Med. Chem., vol. 35, pp. 258-266 (1992).
Lehner et al., Molec. Endocrinol., vol. 1, pp. 377-387 (1987).
Nardulli et al., Molec. Endocr., vol. 7, pp. 331-340 (1993).
Naruto et al., Euro. J. Med. Chem., vol. 20, pp. 529-532 (1985).
Peters et al., J. Med. Chem., vol. 32, pp. 2306-2310 (1989).
Purdy et al., J. Med. Chem., vol. 33, pp. 1572-1581 (1990).
Rowland et al., J. Clin. Pharmacol., vol. 34, pp. 80-85 (1994).
Steinsapir et al., American J. Therapeutics, vol. 1, pp. 236-244 (1994).
Steinsapir et al., The Endocrine Society, (74th Annual Meeting), vol. 109, abs 228 (1992).
Tsai and O'Malley, Ann. Rev. Biochem., vol. 63, pp. 451-486 (1984).
Uberoi et al., Steroids, vol. 45, pp. 325-340 (1985).

Affiliated with

Also associated with

Rating

Design of drugs involving receptor-ligand-DNA interactions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Design of drugs involving receptor-ligand-DNA interactions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Design of drugs involving receptor-ligand-DNA interactions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1213488